As bioinformatic analysis and literature reviews indicated that IGF2BP1 is a plausible target for further research, Western blot, immunohistochemistry, and RT-qPCR were carried out to evaluate the IGF2BP1 mRNA and protein levels in the LUAD tissues and para-carcinoma tissues. The gene discussed is IGF2BP1; the disease is carcinoma.